Molecular regulation of an invasion-related molecule - options for turnour staging and clinical strategies

被引:15
作者
Allgayer, Heike
机构
[1] Heidelberg Univ, Klinikum Mannheim, Dept Expt Surg & Mol Oncol, D-68135 Mannheim, Germany
[2] Heidelberg Univ, Klinikum Mannheim, Joint Unit Mol Oncol Solid Tumours, German Canc Res Ctr, D-68135 Mannheim, Germany
关键词
urokinase-receptor; transcription; in vivo; AP-1; AP-2; Sp1; EMSA;
D O I
10.1016/j.ejca.2006.01.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review provides a summary of the European Association for Cancer Research Award Lecture, presented at the ECCO13 meeting in Paris in November 2005. It is a brief overview on the biological and clinical relevance of the urokinase receptor (u-PAR), an essential molecule to promote invasive and metastatic tumour phenotype and shown to be associated with early relapse and poor prognosis in many different types of cancers. The review summarizes the most important transcriptional mechanisms regulating u-PAR gene, and will focus on the differential binding of transcription factors to u-PAR promoter elements from studies in resected tumour and normal tissues of colorectal and gastric cancer patients. These studies conducted by our group may help to understand transcriptional mechanisms, which are employed to promote invasion and metastasis, in subpopulations of cancer patients. Such studies could lead to a more target-oriented patient selection and therapy against transcriptional and oncogeneic regulators in cancer. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:811 / 819
页数:9
相关论文
共 135 条
  • [1] AGUIRREGHISO JA, 1999, J CELL BIOL, V144, P1285
  • [2] Allgayer H, 1997, CANCER RES, V57, P1394
  • [3] Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor
    Allgayer, H
    Wang, H
    Wang, Y
    Heiss, MM
    Bauer, R
    Nyormoi, O
    Boyd, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) : 4702 - 4714
  • [4] Activation of Src kinase in primary colorectal carcinoma - An indicator of poor clinical prognosis
    Allgayer, H
    Boyd, DD
    Heiss, MM
    Abdalla, EK
    Curley, SA
    Gallick, GE
    [J]. CANCER, 2002, 94 (02) : 344 - 351
  • [5] Allgayer H, 1997, BRIT J SURG, V84, P1651, DOI 10.1046/j.1365-2168.1997.00619.x
  • [6] Allgayer H, 1998, CLIN EXP METASTAS, V16, P62
  • [7] Transcriptional induction of the urokinase receptor gene by a constitutively active Src - Requirement of an upstream motif (-152/-135) bound with Sp1
    Allgayer, H
    Wang, H
    Gallick, GE
    Crabtree, A
    Mazar, A
    Jones, T
    Kraker, AJ
    Boyd, DD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18428 - 18437
  • [8] Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: Investigation of sensitivity and specificity of an immunogold alkaline phosphatase double staining protocol
    Allgayer, H
    Heiss, MM
    Riesenberg, R
    Babic, R
    Jauch, KW
    Schildberg, FW
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1997, 45 (02) : 203 - 212
  • [9] Targeted disruption of the K-Ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis
    Allgayer, H
    Wang, H
    Shirasawa, S
    Sasazuki, T
    Boyd, D
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (12) : 1884 - 1891
  • [10] Ando Y, 1996, J CELL PHYSIOL, V167, P500, DOI 10.1002/(SICI)1097-4652(199606)167:3<500::AID-JCP14>3.0.CO